Stock Quality:
Last 90 days
6.7%
Trailing 12 Months
-13.5%
TLIS RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Historical Charts for Stock Metrics
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2024 | 989.0K | 0 | 0 | 0 |
| 2023 | 2.8M | 2.9M | 2.2M | 2.1M |
| 2022 | 4.4M | 4.8M | 5.4M | 4.8M |
| 2021 | 17.5M | 16.8M | 7.6M | 8.2M |
| 2020 | 0 | 0 | 0 | 10.9M |
| CEO | Mr. Robert Kelley MBA |
|---|---|
| WEBSITE | https://talisbio.com |
| SECTOR | Healthcare |
| INDUSTRY | Medical Devices |
| EMPLOYEES | 102 |